Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05318027 | RECRUITING | Lung Cancer

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Sponsor:

Abramson Cancer Center at Penn Medicine

Brief Summary:

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Condition or disease

Lung Cancer

Gastrointestinal Cancer

Head and Neck Cancer

Intervention/treatment

ChatBot

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 70 participants
Masking : NONE
Primary Purpose : OTHER
Official Title : Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment
Actual Study Start Date : 2023-05-22
Estimated Primary Completion Date : 2025-12
Estimated Study Completion Date : 2025-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Adults (age \>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment.
  • * Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly
  • * Ability read and respond in English
  • * Ability to provide informed consent to participate in the study
Exclusion Criteria
  • * Patients who are bed bound at baseline (ECOG 4)
  • * Patients who rely on a wheelchair for ambulation
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Location Details

NCT05318027

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Pennsylvania

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104